Yahoo Web Search

Search results

    • Small Business - Cordele Dispatch | Cordele Dispatch

      Cordele Dispatch· 3 days ago

      Amgen (NASDAQ:AMGN) and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive ...